Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
19.63
-0.14 (-0.71%)
At close: Sep 04, 2025, 3:59 PM
19.88
1.27%
Pre-market: Sep 05, 2025, 04:00 AM EDT
-0.71% (1D)
Bid | 18.8 |
Market Cap | 1.08B |
Revenue (ttm) | 199.89M |
Net Income (ttm) | 52.48M |
EPS (ttm) | 0.87 |
PE Ratio (ttm) | 22.56 |
Forward PE | -7.01 |
Analyst | Buy |
Ask | 20.41 |
Volume | 669,090 |
Avg. Volume (20D) | 767,012 |
Open | 19.73 |
Previous Close | 19.77 |
Day's Range | 18.80 - 19.88 |
52-Week Range | 5.35 - 20.45 |
Beta | 1.15 |
About STOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol STOK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for STOK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Stoke Therapeutics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+24.98%
Stoke Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+7.04%
Stoke Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced a price target of $30.